Cargando…
Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis
Diabetes mellitus (DM) is a global epidemic causing significant morbidity and mortality. The most occurring DM is type 2 diabetes mellitus (T2DM) which has similar symptoms as type 1 diabetes mellitus (T1DM). However, it is less marked, making it difficult to diagnose during the early stages. The ma...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708052/ https://www.ncbi.nlm.nih.gov/pubmed/36465743 http://dx.doi.org/10.7759/cureus.30879 |
_version_ | 1784840836613144576 |
---|---|
author | Zaki, Hany A Iftikhar, Haris Abdalrubb, Abeer Al-Marri, Nood Dhafi R Abdelrahim, Mohammed Gafar Fayed, Mohamed Elgassim, Mohamed Abdelgadir M Elarref, Mohamed A |
author_facet | Zaki, Hany A Iftikhar, Haris Abdalrubb, Abeer Al-Marri, Nood Dhafi R Abdelrahim, Mohammed Gafar Fayed, Mohamed Elgassim, Mohamed Abdelgadir M Elarref, Mohamed A |
author_sort | Zaki, Hany A |
collection | PubMed |
description | Diabetes mellitus (DM) is a global epidemic causing significant morbidity and mortality. The most occurring DM is type 2 diabetes mellitus (T2DM) which has similar symptoms as type 1 diabetes mellitus (T1DM). However, it is less marked, making it difficult to diagnose during the early stages. The management of T2DM is usually based on weight and glycemic control, which can be achieved through dietary interventions such as intermittent fasting (IF) and the ketogenic diet (KD). Therefore, this systematic review and meta-analysis aim to demonstrate the role of IF and KD in glycemic and weight control among patients with T2DM. Two methods, including an electronic database search through ScienceDirect, Google Scholar, PubMed, Scopus, Embase, and Web of Science, and a manual search were used to identify relevant studies published between 2000 and 2022. The search yielded 1299 articles, of which only 12 met the inclusion criteria. In addition, study quality appraisal was performed using Review Manager software (RevMan 5.4.1). The pooled results have shown that IF had a similar effect on HBA1c reduction as control interventions (standardized mean differences [SMD]: 0.36%; 95% CI; -0.37, 1.10; P = 0.33, I2 = 87%). Similarly, an insignificant difference in weight reduction between IF and control interventions was recorded (SMD: -1.05%; 95% CI; -2.29, 0.19; P = 0.10, I2 = 96%). On the other hand, KD significantly reduced body weight compared with control diets (SMD: -1.91 kg; 95% CI; -2.96 kg, -0.85 kg; P = 0.0004, I2 = 96%). Similarly, KD had a better effect on the HBA1c percentage reduction than control diets (SMD: -2.00%; 95% CI; -3.76, -0.25; P = 0.03, I2 = 97%). IF and KD have shown reductions in HBA1c and body weight among patients with T2DM. However, the interventions are subject to side effects and should be used with caution and under the supervision of a health professional. |
format | Online Article Text |
id | pubmed-9708052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-97080522022-12-01 Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis Zaki, Hany A Iftikhar, Haris Abdalrubb, Abeer Al-Marri, Nood Dhafi R Abdelrahim, Mohammed Gafar Fayed, Mohamed Elgassim, Mohamed Abdelgadir M Elarref, Mohamed A Cureus Endocrinology/Diabetes/Metabolism Diabetes mellitus (DM) is a global epidemic causing significant morbidity and mortality. The most occurring DM is type 2 diabetes mellitus (T2DM) which has similar symptoms as type 1 diabetes mellitus (T1DM). However, it is less marked, making it difficult to diagnose during the early stages. The management of T2DM is usually based on weight and glycemic control, which can be achieved through dietary interventions such as intermittent fasting (IF) and the ketogenic diet (KD). Therefore, this systematic review and meta-analysis aim to demonstrate the role of IF and KD in glycemic and weight control among patients with T2DM. Two methods, including an electronic database search through ScienceDirect, Google Scholar, PubMed, Scopus, Embase, and Web of Science, and a manual search were used to identify relevant studies published between 2000 and 2022. The search yielded 1299 articles, of which only 12 met the inclusion criteria. In addition, study quality appraisal was performed using Review Manager software (RevMan 5.4.1). The pooled results have shown that IF had a similar effect on HBA1c reduction as control interventions (standardized mean differences [SMD]: 0.36%; 95% CI; -0.37, 1.10; P = 0.33, I2 = 87%). Similarly, an insignificant difference in weight reduction between IF and control interventions was recorded (SMD: -1.05%; 95% CI; -2.29, 0.19; P = 0.10, I2 = 96%). On the other hand, KD significantly reduced body weight compared with control diets (SMD: -1.91 kg; 95% CI; -2.96 kg, -0.85 kg; P = 0.0004, I2 = 96%). Similarly, KD had a better effect on the HBA1c percentage reduction than control diets (SMD: -2.00%; 95% CI; -3.76, -0.25; P = 0.03, I2 = 97%). IF and KD have shown reductions in HBA1c and body weight among patients with T2DM. However, the interventions are subject to side effects and should be used with caution and under the supervision of a health professional. Cureus 2022-10-30 /pmc/articles/PMC9708052/ /pubmed/36465743 http://dx.doi.org/10.7759/cureus.30879 Text en Copyright © 2022, Zaki et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Zaki, Hany A Iftikhar, Haris Abdalrubb, Abeer Al-Marri, Nood Dhafi R Abdelrahim, Mohammed Gafar Fayed, Mohamed Elgassim, Mohamed Abdelgadir M Elarref, Mohamed A Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title | Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title_full | Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title_fullStr | Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title_short | Clinical Assessment of Intermittent Fasting With Ketogenic Diet in Glycemic Control and Weight Reduction in Patients With Type II Diabetes Mellitus: A Systematic Review and Meta-Analysis |
title_sort | clinical assessment of intermittent fasting with ketogenic diet in glycemic control and weight reduction in patients with type ii diabetes mellitus: a systematic review and meta-analysis |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708052/ https://www.ncbi.nlm.nih.gov/pubmed/36465743 http://dx.doi.org/10.7759/cureus.30879 |
work_keys_str_mv | AT zakihanya clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT iftikharharis clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT abdalrubbabeer clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT almarrinooddhafir clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT abdelrahimmohammedgafar clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT fayedmohamed clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT elgassimmohamedabdelgadirm clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis AT elarrefmohameda clinicalassessmentofintermittentfastingwithketogenicdietinglycemiccontrolandweightreductioninpatientswithtypeiidiabetesmellitusasystematicreviewandmetaanalysis |